SG48801A1 - Beads having a core coated with an antifungal and a polymer - Google Patents

Beads having a core coated with an antifungal and a polymer

Info

Publication number
SG48801A1
SG48801A1 SG1996001839A SG1996001839A SG48801A1 SG 48801 A1 SG48801 A1 SG 48801A1 SG 1996001839 A SG1996001839 A SG 1996001839A SG 1996001839 A SG1996001839 A SG 1996001839A SG 48801 A1 SG48801 A1 SG 48801A1
Authority
SG
Singapore
Prior art keywords
antifungal
beads
polymer
core coated
coated
Prior art date
Application number
SG1996001839A
Other languages
English (en)
Inventor
Paul M V Gilis
Conde Valentin F V De
Roger P G Vandecruys
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8210890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG48801(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SG48801A1 publication Critical patent/SG48801A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Materials For Medical Uses (AREA)
SG1996001839A 1992-09-03 1993-08-27 Beads having a core coated with an antifungal and a polymer SG48801A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92202664 1992-09-03

Publications (1)

Publication Number Publication Date
SG48801A1 true SG48801A1 (en) 1998-05-18

Family

ID=8210890

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996001839A SG48801A1 (en) 1992-09-03 1993-08-27 Beads having a core coated with an antifungal and a polymer

Country Status (33)

Country Link
US (1) US5633015A (de)
EP (1) EP0658103B1 (de)
JP (1) JP2865869B2 (de)
KR (1) KR0151893B1 (de)
CN (1) CN1034714C (de)
AP (1) AP444A (de)
AT (1) ATE145327T1 (de)
AU (1) AU665867B2 (de)
CA (1) CA2142848C (de)
CY (1) CY2105B1 (de)
CZ (1) CZ283403B6 (de)
DE (1) DE69306119T2 (de)
DK (1) DK0658103T3 (de)
ES (1) ES2097536T3 (de)
FI (1) FI112437B (de)
GR (1) GR3022198T3 (de)
HK (1) HK1006000A1 (de)
HR (1) HRP931158B1 (de)
HU (1) HU220614B1 (de)
IL (1) IL106871A (de)
MX (1) MX9305438A (de)
MY (1) MY109369A (de)
NO (1) NO307953B1 (de)
NZ (1) NZ255379A (de)
OA (1) OA10130A (de)
PH (1) PH30929A (de)
PL (2) PL172676B1 (de)
RU (1) RU2125445C1 (de)
SG (1) SG48801A1 (de)
SI (1) SI9300461B (de)
TW (1) TW376322B (de)
WO (1) WO1994005263A1 (de)
ZA (1) ZA936493B (de)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
PT824344E (pt) 1995-05-09 2005-09-30 Phoqus Pharmaceuticals Ltd Composicao de revestimento em po para revestimento electrostatico de substratos farmaceuticos
US5750147A (en) * 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
DK0904060T3 (da) * 1996-05-20 2004-04-13 Janssen Pharmaceutica Nv Antifungale præparater med forbedret biotilgængelighed
NZ333514A (en) * 1996-06-28 2000-05-26 Schering Corp Oral pharmaceutical composition comprising a triazole antifungal compound
US5846971A (en) * 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
WO1998042318A1 (en) * 1997-03-26 1998-10-01 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
KR19990001564A (ko) * 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
KR100514330B1 (ko) * 1997-12-31 2006-02-17 주식회사 중외제약 난용성 약물을 함유하는 코팅정
EP1039909B1 (de) * 1997-12-31 2002-10-09 Choongwae Pharma Corporation Herstellungsverfahren und zusammensetzung einer oralen zubereitung von itraconazol
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
DK1104291T3 (da) * 1998-07-17 2006-01-16 Janssen Pharmaceutica Nv Pelleter med en kerne, som er coatet med et antisvampemiddel og en polymer
ES2157731B1 (es) * 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
ATE307808T1 (de) 1999-03-24 2005-11-15 Scherer Technologies Inc R P Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
KR100331529B1 (ko) * 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20060034937A1 (en) * 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
KR100694667B1 (ko) * 1999-12-08 2007-03-14 동아제약주식회사 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
EP1239831B1 (de) * 1999-12-23 2012-10-31 Mayne Pharma International Pty Ltd. Verbesserte pharmazeutische zusammensetzungen für schwerlösliche arzneistoffe
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
CN1813753B (zh) * 2000-02-29 2010-04-07 布里斯托尔-迈尔斯斯奎布公司 低剂量艾替开韦制剂及其应用
US6551608B2 (en) * 2000-03-06 2003-04-22 Porex Technologies Corporation Porous plastic media with antiviral or antimicrobial properties and processes for making the same
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US6663897B2 (en) 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
BR0207862A (pt) 2001-02-14 2004-06-22 Tibotec Pharm Ltd Inibidores de protease de hiv 2-(amino-substituìda)-benzotiazol-sulfonamida de amplo espectro
OA12464A (en) 2001-04-09 2006-05-24 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors.
EE05307B1 (et) 2001-05-11 2010-06-15 Tibotec Pharmaceuticals Ltd. Laiaspektrilised 2-aminobensoksasoolsulfoonamiidid kui HIV proteaasi inhibiitorid, nende kasutamine, farmatseutiline kompositsioon ja meetod retroviiruse replikatsiooni inhibeerimiseks
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
KR100438485B1 (ko) * 2001-08-13 2004-07-09 한국디디에스제약 주식회사 아졸류 항진균제의 약제학적 조성물
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
CA2363376A1 (en) * 2001-11-16 2003-05-16 Bernard Charles Sherman Solid pharmaceutical compositions for oral administration comprising itraconazole
CN100448444C (zh) 2001-12-21 2009-01-07 泰博特克药品有限公司 含杂环取代苯基的磺酰胺广谱hiv蛋白酶抑制剂
JP2005523260A (ja) * 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 圧力ノズルを用いた均質噴霧乾燥固体非晶質薬剤分散体の製造方法
US7446107B2 (en) * 2002-02-15 2008-11-04 Transform Pharmaceuticals, Inc. Crystalline forms of conazoles and methods of making and using the same
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
WO2003074474A2 (en) * 2002-03-01 2003-09-12 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US20050025791A1 (en) * 2002-06-21 2005-02-03 Julius Remenar Pharmaceutical compositions with improved dissolution
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
ATE371652T1 (de) 2002-05-17 2007-09-15 Tibotec Pharm Ltd Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
EP1511490A4 (de) * 2002-05-31 2009-03-11 Transform Pharmaceuticals Inc Neue kristalline conazol-formen und verwandte prozesse, pharmazeutische zusammensetzungen und verfahren
US20060013877A1 (en) * 2002-07-22 2006-01-19 Nanohybrid Co., Ltd. Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
AU2003262574B2 (en) 2002-08-14 2009-07-09 Tibotec Pharmaceuticals Ltd. Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors
US20040086567A1 (en) * 2002-10-30 2004-05-06 Pawan Seth Bioequivalent composition of itraconazole and a hydrophilic polymer
BR0215954A (pt) * 2002-11-26 2005-09-13 Uc Tech Métodos de redução da possibilidade de mortalidade em um animal, de expressão virulenta em um patógeno intestinal, e da expressão de adesina / lectina pa-i em uma célula bacteriana, de inibição de expressão de adesina / lectina pa-i em um patógeno intestinal, de ativação induzida por intestino de adesina / lectina pa-i, de mudança morfológica induzida por c4-hsl de um patógeno intestinal, e de aderência de célula bacteriana em um intestino de mamìfero, de melhoria de patogênese intestinal, de prevenção de uma doença ou condição anormal, de infecção de pele e respiratória, de uma doença sexualmente transmitida, de um distúrbio de trato digestivo, de perda de capacidade lactante em um animal, e de desenvolvimento de um distúrbio epitelial mediado por micróbio em uma animal de idade de amamentação, de irrigação de pelo menos uma porção do trato urinário, e para monitoração da administração de poli (etileno-glicol) (peg) a um animal, composição farmacêutica, kits para a prevenção ou tratamento terapêutico de sepsia derivada de intestino, e para a monitoração da administração de poli (etileno-glicol), e, preservativo
US8183290B2 (en) * 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
SI1438960T2 (sl) * 2003-01-14 2013-04-30 Cimex Pharma Ag Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljšano biorazpoložljivostjo
DK1438961T4 (da) * 2003-01-14 2014-11-17 Acino Pharma Ag Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
WO2005023242A1 (en) 2003-09-11 2005-03-17 Tibotec Pharmaceuticals Ltd. Entry inhibitors of the hiv virus
US20050074494A1 (en) * 2003-10-06 2005-04-07 Xiu-Xiu Cheng Itraconazole immediate release formulation
US20050118265A1 (en) * 2003-11-28 2005-06-02 Anandi Krishnan Antifungal oral dosage forms and the methods for preparation
US9247765B2 (en) 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
US20050249799A1 (en) * 2004-03-03 2005-11-10 Spherics, Inc. Polymeric drug delivery system for hydrophobic drugs
GB0407312D0 (en) 2004-03-31 2004-05-05 Phoqus Pharmaceuticals Ltd Method and apparatus for the application of powder material to substrates
AR048650A1 (es) 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
MXPA06012909A (es) 2004-05-07 2007-09-06 Sequoia Pharmaceuticals Inc Inhibidores de proteasa retroviral repelente de resistencia.
BRPI0511267A (pt) 2004-05-17 2007-11-27 Tibotec Pharm Ltd 1,5-diidropirido[3,2-b]indol-2-onas 4-substituìdas
MXPA06013314A (es) 2004-05-17 2007-02-02 Tibotec Pharm Ltd 1-heterociclil-1,5-dihidro-pirido[3,2-b]indol-2-onas.
WO2005111035A1 (en) 2004-05-17 2005-11-24 Tibotec Pharmaceuticals Ltd. 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones useful as anti-infective pharmaceutical agents
US20060045865A1 (en) * 2004-08-27 2006-03-02 Spherics, Inc. Controlled regional oral delivery
WO2006026504A2 (en) * 2004-08-27 2006-03-09 Spherics, Inc. Mucoadhesive oral formulations of high permeability, high solubility drugs
US20060045822A1 (en) 2004-09-01 2006-03-02 Board Of Regents, The University Of Texas System Plasma polymerization for encapsulating particles
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
AR056652A1 (es) 2005-04-11 2007-10-17 Tibotec Pharm Ltd Derivados de (1,10-b dihidro-2-(aminoalquil-fenil) -5h-pirazolo (1,5-c) (1,3)benzoxazin-5-il) fenilmetanona y su uso en la fabricacion de un medicamento
CA2615799A1 (en) * 2005-07-21 2007-02-01 Nomir Medical Technologies, Inc. Near infrared microbial elimination laser system (nimels)
US20070148240A1 (en) * 2005-12-23 2007-06-28 Fang-Yu Lee Oral formulation containing itraconazole and methods for manufacturing and using the same
CA2646090A1 (en) 2006-04-03 2007-10-11 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
CN101091725A (zh) * 2006-06-23 2007-12-26 天津天士力制药股份有限公司 一种中药颗粒及其制备方法
EP2134327A1 (de) * 2007-03-13 2009-12-23 Sandoz AG Pharmazeutische zusammensetzungen schlecht löslicher arzneimittel
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US7314641B1 (en) 2007-04-18 2008-01-01 Everest Pharm. Industrial Co., Ltd. High-bioavailability particle coated with fungicide and polymer
JP2008280254A (ja) * 2007-05-08 2008-11-20 Everest Pharm Industrial Co Ltd 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
BRPI0819883A2 (pt) 2007-11-28 2017-05-23 Sequoia Pharmaceuticals Inc composições e métodos para inibir citocromo p450 2d6
US8906647B2 (en) 2008-02-21 2014-12-09 Sequoia Pharmaceuticals, Inc. Diamide inhibitors of cytochrome P450
EP2262851B1 (de) 2008-03-13 2017-09-27 Board of Regents, The University of Texas System Kovalent funktionalisierte teilchen zur synthese neuer verbundwerkstoffe
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
WO2011146078A1 (en) * 2010-05-21 2011-11-24 Board Of Regents, The University Of Texas System Encapsulated particles for enteric release
WO2011146077A1 (en) * 2010-05-21 2011-11-24 Board Of Regents, The University Of Texas System Encapsulated particles for amorphous stability enhancement
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
RU2618456C2 (ru) * 2010-12-16 2017-05-03 Плэтформ Брайтворкс Ту, Лтд Фармацевтические препараты азолов для парентерального введения и способы их получения и применения для лечения заболеваний, чувствительных к азольным соединениям
WO2012154774A1 (en) 2011-05-10 2012-11-15 Theravida, Inc. Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder
WO2013192566A1 (en) 2012-06-21 2013-12-27 Mayne Pharma International Pty. Ltd. Itraconazole compositions and dosage forms, and methods of using the same
CN103948911B (zh) * 2014-04-23 2016-04-20 深圳市健元医药科技有限公司 一种棘白菌素类抗真菌药物缓释微球制剂及其制备方法
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
WO2017127073A1 (en) 2016-01-20 2017-07-27 Theravida, Inc. Methods and compositions for treating hyperhidrosis
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease
EP4452232A1 (de) * 2021-12-22 2024-10-30 Palau Pharma, S.L.U. Multipartikuläre albaconazolzusammensetzung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
JPH01165520A (ja) * 1987-12-23 1989-06-29 Shin Etsu Chem Co Ltd 持続性製剤およびその製造方法
US5049374A (en) * 1989-11-28 1991-09-17 Dansereau Richard J Oral (coated bead) dosage form for sodium iodide I-131
US5213811A (en) * 1991-09-13 1993-05-25 Sterling Drug Inc. Oral sustained-release drug compositions

Also Published As

Publication number Publication date
DK0658103T3 (da) 1996-12-09
CY2105B1 (en) 2002-04-26
HUT70419A (en) 1995-10-30
CN1088432A (zh) 1994-06-29
AU4954693A (en) 1994-03-29
WO1994005263A1 (en) 1994-03-17
NO950829L (no) 1995-05-02
SI9300461B (en) 2001-12-31
EP0658103A1 (de) 1995-06-21
PL172676B1 (pl) 1997-11-28
MY109369A (en) 1997-01-31
JPH08501092A (ja) 1996-02-06
CA2142848A1 (en) 1994-03-17
RU2125445C1 (ru) 1999-01-27
ZA936493B (en) 1995-03-02
FI950975A0 (fi) 1995-03-02
FI950975L (fi) 1995-03-02
NO950829D0 (no) 1995-03-02
AU665867B2 (en) 1996-01-18
GR3022198T3 (en) 1997-03-31
SI9300461A (en) 1994-03-31
AP9300563A0 (en) 1993-10-31
PL307791A1 (en) 1995-06-26
TW376322B (en) 1999-12-11
OA10130A (en) 1996-12-18
ATE145327T1 (de) 1996-12-15
US5633015A (en) 1997-05-27
MX9305438A (es) 1994-03-31
NZ255379A (en) 1996-06-25
ES2097536T3 (es) 1997-04-01
PL174178B1 (pl) 1998-06-30
CA2142848C (en) 1999-11-16
HU9500642D0 (en) 1995-04-28
HU220614B1 (hu) 2002-03-28
FI112437B (fi) 2003-12-15
CZ54295A3 (en) 1995-09-13
NO307953B1 (no) 2000-06-26
CN1034714C (zh) 1997-04-30
HRP931158B1 (en) 1999-02-28
IL106871A (en) 1998-02-22
JP2865869B2 (ja) 1999-03-08
HK1006000A1 (en) 1999-02-05
DE69306119D1 (de) 1997-01-02
PH30929A (en) 1997-12-23
CZ283403B6 (cs) 1998-04-15
IL106871A0 (en) 1993-12-28
HRP931158A2 (en) 1995-06-30
AP444A (en) 1996-01-19
EP0658103B1 (de) 1996-11-20
DE69306119T2 (de) 1997-03-13
KR0151893B1 (ko) 1998-10-15

Similar Documents

Publication Publication Date Title
IL106871A0 (en) Beads having a core coated with an antifungal and a polymer
AP9901516A0 (en) Pellets having a core coated with an antifungal and a polymer
IL137665A0 (en) Pellets having core coated with an antifungal and a polymer
PL316966A1 (en) Amoxycyclin and clavulate containing tablets coated with a polymeric material
GB2241889B (en) Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
IL109821A0 (en) A crosslinker and a method of crosslinking a coating binder polymer
AU7598194A (en) A coating
EP0448302A3 (en) Carbon-clad inorganic oxide particles and the same with a polymer coating thereon
ZA942631B (en) Use of a coating comprising an acid-functional polymer and an organosilane
GB9520096D0 (en) A seed with a magnetic coating
GB2284750B (en) Applicator equipped with a flexible application member and assembly comprising such an applicator
PL358909A1 (en) Pellets having a core coated with a lipid lowering agent and a polymer
AU5273193A (en) A polyolefinic resin and a resin composition comprising said resin
KR0168637B1 (en) Mar-resistant coating
AU5175493A (en) A program unit of the prom-type and a marker with such a unit
AU5752790A (en) A coating agent and coated materials thereof
GB2292094B (en) A dart barrel and point assembly
SG32358A1 (en) Plastic coating thread and coupling assembly
GB9312616D0 (en) A voice and data network
EP0644366A3 (en) Flange connection with a fixed and a loose flange.
HU9401925D0 (en) Tap with plastic coating
GB9417679D0 (en) In-mould coating of a polymer
AU119914S (en) A gudgeon